Ann & Robert H Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
NCT Number: NCT00179946
The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
Looking for future studies?
Notify MeAll sexes
Observational
Chicago, Illinois, 60611, United States
The aim of this protocol is to clarify the role of HLA matching in unrelated umbilical cord blood (UCB) transplantation and to identify the level of HLA matching required assuring successful outcome of unrelated UCB transplantation.
The study will answer the following questions:
By studying the cells and blood of donors and recipients, we may learn more about improving the tissue matching between unrelated donors and their recipients. Also, we hope to learn if an additional level of matching testing improves the results of the transplant treatment. Increasing knowledge about tissue matching could result in the improved long-term survival of cord blood transplant recipients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ann & Robert H Lurie Children's Hospital of Chicago
Other
Impact of HLA Matching on Outcome in Pediatric Patients Undergoing Unrelated Umbilical Cord Blood Transplantation.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02343965
Anxiety Disorders, Hematologic Diseases
Nantes, France
View Trial DetailsNCT06187831
Bleeding, Blood Platelet Disorders
Lund, Lunds Universitet, Sweden
View Trial DetailsNCT03578367
Bone Marrow Diseases, CML
Augusta, Georgia, United States
View Trial DetailsNCT03030248
Bacterial Infections, Bacterial Infections and Mycoses
Milwaukee, Wisconsin, United States
View Trial Details